<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Cell and Tissue Biology</journal-id><journal-title-group><journal-title xml:lang="en">Cell and Tissue Biology</journal-title><trans-title-group xml:lang="ru"><trans-title>Цитология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0041-3771</issn><issn publication-format="electronic">3034-6061</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">669661</article-id><article-id pub-id-type="doi">10.31857/S0041377123010091</article-id><article-id pub-id-type="edn">GLDCGD</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The Role of the Notch Signaling Pathway in the Pathogenesis of Lung Diseases of Non-infectious Etiology</article-title><trans-title-group xml:lang="ru"><trans-title>Роль сигнального пути NOTCH в патогенезе заболеваний легких неинфекционной этиологии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Serebryakova</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Серебрякова</surname><given-names>В. А.</given-names></name></name-alternatives><email>serebryakova-val@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sanina</surname><given-names>A. E.</given-names></name><name xml:lang="ru"><surname>Санина</surname><given-names>А. Е.</given-names></name></name-alternatives><email>serebryakova-val@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Urazova</surname><given-names>O. I.</given-names></name><name xml:lang="ru"><surname>Уразова</surname><given-names>О. И.</given-names></name></name-alternatives><email>serebryakova-val@mail.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gadzhiev</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Гаджиев</surname><given-names>А. А.</given-names></name></name-alternatives><email>serebryakova-val@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Stepanova</surname><given-names>E. P.</given-names></name><name xml:lang="ru"><surname>Степанова</surname><given-names>Е. П.</given-names></name></name-alternatives><email>serebryakova-val@mail.ru</email><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Pharmacology Department of Siberian State Medical University</institution></aff><aff><institution xml:lang="ru">Кафедра фармакологии Сибирского государственного медицинского университета</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Pathophysiology Department of Siberian State Medical University</institution></aff><aff><institution xml:lang="ru">Кафедра патофизиологии Сибирского государственного медицинского университета</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Tomsk State University of Control Systems and Radioelectronics</institution></aff><aff><institution xml:lang="ru">Томский государственный университет систем управления и радиоэлектроники</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Tomsk Phthisiopulmonological Medical Center</institution></aff><aff><institution xml:lang="ru">Томский фтизиопульмонологический медицинский центр</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2023-01-01"><day>01</day><month>01</month><year>2023</year></pub-date><pub-date date-type="collection"><year>2023</year></pub-date><volume>65</volume><issue>1</issue><fpage>3</fpage><lpage>10</lpage><history><date date-type="received" iso-8601-date="2025-02-27"><day>27</day><month>02</month><year>2025</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2025-02-27"><day>27</day><month>02</month><year>2025</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2023-01-01"><day>01</day><month>01</month><year>2023</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, В.А. Серебрякова, А.Е. Санина, О.И. Уразова, А.А. Гаджиев, Е.П. Степанова</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, В.А. Серебрякова, А.Е. Санина, О.И. Уразова, А.А. Гаджиев, Е.П. Степанова</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">В.А. Серебрякова, А.Е. Санина, О.И. Уразова, А.А. Гаджиев, Е.П. Степанова</copyright-holder><copyright-holder xml:lang="ru">В.А. Серебрякова, А.Е. Санина, О.И. Уразова, А.А. Гаджиев, Е.П. Степанова</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0041-3771/article/view/669661">https://journals.eco-vector.com/0041-3771/article/view/669661</self-uri><abstract xml:lang="en"><p id="idm45181324446512">A review of current literature data on the significance of the Notch signaling pathway in the mechanisms of the development of diseases of the respiratory system – chronic obstructive pulmonary disease (COPD), bronchial asthma (BA) and lung cancer is presented. In studies of lung tissue samples of patients with COPD and lung tissues of mice, it was found that activation of the Notch signaling pathway promotes metaplasia and increases the functional activity of goblet cells, protects epithelial cells from apoptosis and oxidative stress. Suppression of the Notch−Jagged1/Jagged2 pathway is associated with the transdifferentiation of club-shaped cells into ciliated ones. In patients with AD, the Notch signaling pathway promotes differentiation of Th2 lymphocytes. In the ovalbumin-induced bronchial asthma model, the Notch cascade increases the imbalance of Th17/Treg lymphocyte populations, the production of IL-4, IL-5, IL-13, IL-17, the formation of allergen-specific IgE, eosinophilic infiltration and metaplasia of goblet-shaped epithelial cells of the respiratory tract. A decrease in the concentration of IgE, Th2-type cytokines (IL-4, IL‑5, IL-13), an increase in the number of Treg cells and the level of TGFß in bronchoalveolar lavage in mice with asthma, mediated by the introduction of dendritic cells expressing the ligands DLL1 and Jagged1, indicates the protective role of the Notch signaling pathway. On samples of tumor tissue and cell lines of non-small cell lung cancer, it was found that an increase in the expression of Notch-1 and Notch-3 mRNA is associated with increased proliferative activity, malignant cell transformation, a high risk of metastasis to lymph nodes and an unfavorable prognosis of the disease. In the samples of tumor tissue of small cell lung cancer, an increase in the expression of the Notch ligand DLK1 signaling inhibitor gene, the Ascl1 transcription factor gene and lysine-specific histone demethylase 1 (LSD1) was recorded. Suppression of LSD1 activity is accompanied by reactivation of signaling via Notch-1 receptor and subsequent inhibition of the transcription factor Ascl1, which induces the initial stages of tumor transformation.</p></abstract><trans-abstract xml:lang="ru"><p id="idm45181324442144">Представлен обзор современных данных литературы о значении сигнального пути Notch в механизмах развития заболеваний респираторной системы – хронической обструктивной болезни легких (ХОБЛ), бронхиальной астмы (БА) и рака легкого. В исследованиях образцов тканей легких больных с ХОБЛ и тканей легких мышей установлено, что активация сигнального пути Notch способствует метаплазии и повышению функциональной активности бокаловидных клеток, защищает эпителиальные клетки от апоптоза и окислительного стресса. Подавление пути Notch–Jagged1/Jagged2 ассоциировано с трансдифференцировкой булавовидных клеток в ресничатые. У больных БА сигнальный путь Notch способствует дифференцировке Тh2-лимфоцитов. В модели бронхиальной астмы, индуцированной овальбумином, каскад Notch увеличивает дисбаланс популяций лимфоцитов Th17/Treg, продукцию IL-4, IL-5, IL-13, IL-17, образование аллерген-специфических IgE, эозинофильную инфильтрацию и метаплазию бокаловидных клеток эпителия дыхательных путей. Снижение концентрации IgE, цитокинов типа Th2 (IL-4, IL-5, IL-13), увеличение числа Treg-клеток и уровня TGFβ в бронхоальвеолярном лаваже у мышей с астмой, опосредованное введением дендритных клеток, экспрессирующих лиганды DLL1 и Jagged1, свидетельствует о протективной роли сигнального пути Notch. На образцах опухолевой ткани и линии клеток немелкоклеточного рака легкого установлено, что увеличение экспрессии мРНК Notch-1 и Notch-3 связано с повышением пролиферативной активности, злокачественной трансформацией клеток, высоким риском метастазирования в лимфатические узлы и неблагоприятным прогнозом заболевания. В образцах опухолевой ткани мелкоклеточного рака легкого регистрируется повышение экспрессии гена ингибитора передачи сигналов Notch – лиганда DLK1, гена фактора транскрипции Ascl1 и лизин-специфической гистондеметилазы 1 (LSD1). Подавление активности LSD1 сопровождается реактивацией передачи сигналов через Notch-1-рецептор и последующим угнетением фактора транскрипции Ascl1, индуцирующего начальные стадии опухолевой трансформации.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Notch</kwd><kwd>chronic obstructive pulmonary disease</kwd><kwd>bronchial asthma</kwd><kwd>lung cancer</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Notch</kwd><kwd>хроническая обструктивная болезнь легких</kwd><kwd>бронхиальная астма</kwd><kwd>рак легкого</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Ишутина О.В. 2021. Сурфактантная система лeгких. Обзорная статья. Вестник ВГМУ. Т. 20. № 4. С. 7. https://doi.org/ (Ishutsina O.V. 2021. The surfactant system of the lungs. A review article. Vestnik VGMU Т. 20. № 4. С. 7. https://doi.org/10.22263/2312-4156.2021.4.7)</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Целуйко С.С., Намаконова В.С., Красавина Н.П., Чжоу С.Д., Ли Ц. 2014. Идентификация и локализация стволовых клеток в органах дыхательной системы (обзор литературы). Бюллетень физиологии и патологии дыхания. № 52. С. 121. (Tseluyko S.S., Namakonova V.S., Krasavina N.P., Zhou X., Li Q. 2014. Identification and localization of stem cells in the respiratory system (review). Bulletin Physiology and Pathology of Respiration. V. 52. P. 121).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Agustí A., Vogelmeier C., Faner R. 2020. COPD 2020: changes and challenges. Am. J. Physiol. Lung Cell. Mol. Physiol. V. 319. P. L879. https://doi.org/10.1152/ajplung.00429.2020</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Augert A., Eastwood E., Ibrahim A.H., Wu N., Grunblatt E., Basom R., Liggitt D., Eaton K.D., Martins R., Poirier J.T., Rudin C.M., Milletti F., Cheng W.Y., Mack F., MacPherson D. et al. 2019. Targeting NOTCH activation in small cell lungcancer through LSD1 inhibition. Sci. Signal. V. 12. P. 2922. https://doi.org/10.1126/scisignal.aau2922</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bagdonas E., Raudoniute J., Bruzauskaite I., Aldonyte R. 2015. Novel aspects of pathogenesis and regeneration mechanisms in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. V. 10. P. 995. https://doi.org/ d.s82518https://doi.org/10.2147/cop</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Baumgart A., Seidl S., Vlachu P., Michel L., Mitova N., Schatz N., Specht K., Koch I., Schuster T., Grundler R., Kremer M., Fend F., Siweke J.T., Peschel S., Duister J. et al. 2010. ADAM17 regulates the expression of the epidermal growth factor receptor by activating Notch1 extra-small cell lung cancer. Cancer Res. V. 70. P. 5368. https://doi.org/10.1158/0008-5472</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Boucherat O., Chakir J., Jeannotte L. 2012. The loss of Hoxa5 function promotes Notch-dependent goblet cell metaplasia in lung airways. Biol. Open. V. 1. P. 677. https://doi.org/10.1242/bio.20121701</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Cai W.X., Liang L., Wang L., Han J.T., Zhu X.X., Han H., Hu D.H., Zhang P. 2014. Inhibition of Notch signaling leads to increased intracellular ROS by up-regulating Nox4 expression in primary HUVECs. Cell Immunol. V. 287. P. 129. https://doi.org/10.1016/j.cellimm.2013.12.009</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Chen C.Y., Chen Y.Y., Hsieh M.S., Ho C.C., Chen K.Y., Shih J.Y., Yu C.J. 2017. Expression of Notch Gene and Its Impact on Survival of Patients with Resectable Non-small Cell Lung Cancer. J. Cancer. V. 8. P. 1292. https://doi.org/10.7150/jca.17741</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Chen Y., Jie V., Yan V., Zhou K., Xiao Y. 2012. Lysine-specific histone demethylase 1 (LSD1): a potential molecular target for tumor therapy. Crit. Rev. Eukaryotic Gene Expression. V. 22. P. 53. https://doi.org/10.1615/critreveukargeneexpr.v22.i1.40</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Galluzzo P., Bocchetta M. 2011. Notch signaling in lung cancer. Expert Rev. Anticancer Ther. V. 11. P. 533. https://doi.org/10.1586/era.10.158</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>George J., Lim J.S., Chan S.J., Kun W., Ozretic L., Kong G., Lenders F., Lu H., Fernandez-Cuesta L., Bosco G., Muller S., Damen I., Yahchan N.S., Park K.S., Yang D. et al. 2015. Complex genomic profiles of small cell lung cancer. Nature. V. 524. P. 47. https://doi.org/10.1038/nature14664</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>He Z., Wu J., Zeng X., Bao H., Liu X. 2021. Role of the Notch ligands Jagged1 and Delta4 in Th17/Treg immune imbalance in a mouse model of chronic asthma. Exp. Lung Res. V. 47. P. 289. https://doi.org/10.1080/01902148.2021.1933653</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hua S., Liu F., Wang M. 2019. Emodin Alleviates the Airway Inflammation of Cough Variant Asthma in Mice by Regulating the Notch Pathway. Med. Sci. Monit. V. 25. P. 5621. https://doi.org/10.12659/MSM.915080</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Huang M.T., Chiu C.J., Chiang B.L. 2019. Multi-Faceted Notch in Allergic Airway Inflammation. Int. J. Mol. Sci. V. 20. P. 3508. https://doi.org/10.3390/ijms20143508</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Huang Q., Han L., Lv R., Ling L. 2019. Magnolol exerts anti-asthmatic effects by regulating Janus kinase-signal transduction and activation of transcription and Notch signaling pathways and modulating Th1/Th2/Th17 cytokines in ovalbumin-sensitized asthmatic mice. Korean J. Physiol. Pharmacol. V. 23. P. 251. https://doi.org/10.4196/kjpp.2019.23.4.251</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Kared H., Adle-Biassette H., Foïs E., Masson A., Bach J., Chatenoud L. 2006. Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling. Immunity. V. 25. 823. https://doi.org/10.1016/j.immuni.2006.09.008</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Katoh M., Katoh M. 2020. Precision medicine for the treatment of human cancer with impaired regulation of Notch signal transmission (review). Int. J. Mol. Med. V. 45. P. 279. https://doi.org/10.3892/ijmm.2019.4418</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Kiyokawa H., Morimoto M. 2020. Notch signaling in the mammalian respiratory system, specifically the trachea and lungs, in development, homeostasis, regeneration, and disease. Dev. Growth Differ. V. 62. P. 67. https://doi.org/10.1111/dgd.12628</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Lee C.C., Lin C.L., Leu S.J., Lee Y.L. 2018. Overexpression of Notch ligand Delta-like-1 by dendritic cells enhances their immunoregulatory capacity and exerts antiallergic effects on Th2-mediated allergic asthma in mice. Clin. Immunol. V. 187. P. 58. https://doi.org/10.1016/j.clim.2017.10.005</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Leonetti A., Facchinetti F., Minari R., Cortellini A., Rolfo K.D., Giovannetti E., Tiseo M. 2019. The Notch pathway in small cell lung cancer: from preclinical data to therapeutic problems. Cell. Oncol. (Dordr). V. 42. P. 261. https://doi.org/10.1007/s13402-019-00441-3</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Lim J.S., Ibaseta A., Fischer M.M., Cancilla B., O’Young G., Cristea S., Luca V.C., Yang D., Jahchan N.S., Hamard C., Antoine M., Wislez M., Kong C., Cain J., Liu Y.W. et al. 2017. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature. V. 545. P. 360. https://doi.org/10.1038/nature22323</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Limbourg F.P., Takeshita K., Radtke F., Bronson R.T., Chin M.T., Liao J.K. 2005. Essential role of endothelial Notch1 in angiogenesis. Circulation. V. 111. P. 1826. https://doi.org/10.1161/01.CIR.0000160870.93058.DD</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Lin C.L., Huang H.M., Hsieh C.L., Fan C.K., Lee Y.L. 2019. Jagged1-expressing adenovirus-infected dendritic cells induce expansion of Foxp3+ regulatory T cells and alleviate T helper type 2-mediated allergic asthma in mice. Immunology. V. 156. P. 199. https://doi.org/10.1111/imm.13021</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Luo J., Li L., Hu D., Zhang X. 2020. LINC00612/miR-31-5p/Notch1 Axis Regulates Apoptosis, Inflammation, and Oxidative Stress in Human Pulmonary Microvascular Endothelial Cells Induced by Cigarette Smoke Extract. Int. J. Chron. Obstruct. Pulmon. Dis. V. 15. P. 2049. https://doi.org/10.2147/COPD.S255696</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Ma J., Rubin B.K., Voynow J.A. 2018. Mucins, Mucus, and Goblet Cells. Chest. V. 154. P. 169. https://doi.org/10.1016/j.chest.2017.11.008</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Morianos I., Semitekolou M. 2020. Dendritic Cells: Critical Regulators of Allergic Asthma. Int. J. Mol. Sci. V. 21. P. 7930. https://doi.org/10.3390/ijms21217930</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Morimoto M., Liu Z., Cheng H.T., Winters N., Bader D., Kopan R. 2010. Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J. Cell. Sci. V. 123. P. 213. https://doi.org/10.1242/jcs.058669</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Motooka Y., Fujino K., Sato Y., Kudoh S., Suzuki M., Ito T. 2017. Pathobiology of Notch2 in lung cancer. Pathology. V. 49. P. 486. https://doi.org/10.1016/j.pathol.2017.05.005</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Nie Y., Yang B., Hu J., Zhang L., Ma Z. 2021. Bruceine D ameliorates the balance of Th1/Th2 in a mouse model of ovalbumin-induced allergic asthma via inhibiting the NOTCH pathway. Allergol. Immunopathol. (Madr). V. 49. P. 73. https://doi.org/10.15586/aei.v49i6.499</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Ostedgaard L.S., Moninger T.O., McMenimen J.D., Sawin N.M., Parker C.P., Thornell I.M., Powers L.S., Gansemer N.D., Bouzek D.C., Cook D.P., Meyerholz D.K., Abou Alaiwa M.H., Stoltz D.A., Welsh M.J. 2017. Gel-forming mucins form distinct morphologic structures in airways. Proc. Natl. Acad. Sc.i USA. V. 114. P. 6842. https://doi.org/10.1073/pnas.1703228114</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Owen D.H., Giffin M.J., Baylis J.M., Smith M.D., Carbone D.P., On K. 2019. DLL3: a new target in small cell lung cancer. J. Hematol. Oncol. V. 12. P. 61. https://doi.org/10.1186/s13045-019-0745-2</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Pancevich-Wojtkiewicz J. 2016. Epidermal growth factor receptor and notch signaling in non-small cell lung cancer. Cancer Med. V. 5. P. 3572. https://doi.org/10.1002/cam4.944</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Qin X., Zhang Z., Xu H., Wu Y. 2011. Notch signaling protects retina from nuclear factor-κB- and poly-ADP-ribose-polymerase-mediated apoptosis under high-glucose stimulation. Acta Biochim. Biophys. Sin. (Shanghai). V. 43. P. 703. https://doi.org/10.1093/abbs/gmr069</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Sharif A., Shaji A., Chammaa M., Pawlik E., Fernandez-Valdivia R. Sharif A. et al. 2020. Notch Transduction in Non-Small Cell Lung Cancer. Int. J. Mol. Sci. V. 21. P. 5691. https://doi.org/10.3390/ijms21165691</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Sinha K., Das J., Pal P.B., Sil P.S. 2013. Oxidative stress: mitochondrial-dependent and mitochondrial-independent pathways of apoptosis. Arch. Toxicol. V. 87. P. 1157. https://doi.org/10.1007/s00204-013-1034-4</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Small R. J., Bacmeister J., Bailey D., Baker A., Bishop S., Bryan F., Caron J., Dennis J., Gent P., Hsu H.M., Jochum M., Lawrence D., Muñoz E., diNezio P., Scheitlin T. et al. 2014. A new synoptic scale resolving global climate simulation using the community earth system model. J. Adv. Model. Earth Syst. V. 6. P. 1065. https://doi.org/10.1002/2014MS000363</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Sosa Iglesias V., Juranno L., Dubois L.J., Theis J., Voice M. 2018. Drug resistance in non-small cell lung cancer: potential for targeting NOTCH? Front. Oncol. V. 8. P. 267. https://doi.org/10.3389/fonc.2018.00267</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Sparaneo A., Fabrizio F.P., Muscarella L.A. 2016. Transmission of Nrf2 and Notch signals in lung cancer: near the intersection. Oxid. Med. Cell. Longev. V. 2016. P. 7316492. https://doi.org/10.1155/2016/7316492</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Tindemans I., van Schoonhoven A., KleinJan A., de Bruijn M.J., Lukkes M., van Nimwegen M., van den Branden A., Bergen I.M., Corneth O.B., van IJcken W.F., Stadhouders R., Hendriks R.W. 2020. Notch signaling licenses allergic airway inflammation by promoting Th2 cell lymph node egress. J. Clin. Invest. V. 130. P. 3576. https://doi.org/10.1172/JCI128310</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Tsao P., Wei S., Wu M., Huang M., Lin H., Lee M. 2011. Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. Development. V. 138. P. 3533. https://doi.org/10.1242/dev.063727</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Wang Y., Xu J., Meng Y., Adcock I.M., Yao X. 2018. Role of inflammatory cells in airway remodeling in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. V. 13. P. 3341. https://doi.org/10.2147/COPD.S176122</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Whitsett J.A. 2018. Airway Epithelial Differentiation and Mucociliary Clearance. Ann. Am. Thorac. Soc. V. 15. P. S143. https://doi.org/10.1513/AnnalsATS.201802-128AW</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Yu L., Li J. 2022. Punicalagin Alleviates Aged Bronchial Asthma by Inhibiting Th2 Differentiation through IL-4/STAT6 and Jagged1/Notch Pathways. J. Healthc. Eng. V. 2022. P. 1184677. https://doi.org/10.1155/2022/1184677</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Zeng Z., Wang L., Ma W., Zheng R., Zhang H., Zeng X., Zhang H., Zhang W. 2019. Inhibiting the Notch signaling pathway suppresses Th17-associated airway hyperresponsiveness in obese asthmatic mice. Lab. Invest. V. 99. P. 1784. https://doi.org/10.1038/s41374-019-0294-x</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Zhou B., Lin W., Long Y., Yang Y., Zhang H., Wu K., Chu Q. 2022. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct. Target. Ther. V. 7. P. 95. https://doi.org/10.1038/s41392-022-00934-y</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Zong D., Ouyang R., Li J., Chen Y., Chen P. 2016. Notch signaling in lung diseases: focus on Notch1 and Notch3. Ther. Adv. Respir. Dis. V. 10. P. 468. https://doi.org/10.1177/1753465816654873</mixed-citation></ref></ref-list></back></article>
